CAMBRIDGE, England, January 20, 2026--biomodal, an omics-based life sciences technology and analytics company, today announced the publication of a study in Nature Communications Medicine showcasing ...

Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study 18 total abstracts to showcase significant developments in ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment. A study supported by ...

Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study 18 total abstracts to showcase significant developments in ...

Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early. While the concept is promising, these untested tests currently pose ...

MCED is able to detect multiple cancer types by analyzing cfDNAs, cfRNAs, circulating proteins and metabolites using liquid-based biopsy techniques and AI algorithms. The TOO results of an MCED test ...

Water damage remains one of the most costly and disruptive problems in both residential and commercial spaces. Often triggered by unnoticed leaks from appliances, HVAC systems, or plumbing, it can ...

(a) Deep learning-based circulating exosome analysis for lung cancer detection (copyright American Chemical Society, 2024); (b) The operational mechanism of the Förster resonance energy transfer (FRET ...

Freenome, developer of tests that identify early signs of cancer from a small sample of patient blood, is going public in a merger deal that will infuse the company with $330 million to support a ...

This module demonstrates how different liquids have different resistance values. The Raspberry Pi is able to identify what the liquid is based on these different resistance values. The program ...